Directory
>
Bassil Dahiyat
Bassil Dahiyat
Board Of Directors | Kodiak Sciences
Monrovia, California, United States
Bassil Dahiyat
Summary
Bassil Dahiyat is an accomplished CEO at Xencor with extensive expertise in the biopharmaceutical and biotechnology sectors. With a PhD in Chemistry from Caltech and a background in Biomedical Engineering from Johns Hopkins University, he has a strong foundation in both scientific research and commercial application. His leadership experience spans over two decades in the industry, where he has contributed to significant advancements in drug development and commercialization. As a board member at Kodiak Sciences, Bassil plays a vital role in guiding innovative research in commercial physical research. His work focuses on critical areas such as cancer, immunology, and infectious diseases, making him a key player in the fight against complex health challenges. Bassil's commitment to technology transfer and R&D reflects his dedication to advancing the life sciences. He is recognized for his strategic vision and ability to drive growth in competitive markets.
Bassil Dahiyat
Work Experience
Board Of Directors at
Kodiak Sciences
July 2018 - Present
CEO at
Xencor
January 1997 - Present
Bassil Dahiyat
Education
Caltech, Phd
January 1992 - January 1997
Johns Hopkins University, Bs/Mse
January 1987 - January 1992
Frequently Asked Questions about Bassil Dahiyat
What is Bassil Dahiyat email address?
Bassil Dahiyat's primary email address is **************@xencor.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Bassil Dahiyat work for?
Bassil Dahiyat is a Board Of Directors at Kodiak Sciences, a company specializing in Commercial physical research.
Where Bassil Dahiyat graduated from?
Bassil Dahiyat holds a degree in Chemistry from Caltech.
How can I directly contact Bassil Dahiyat?
To contact Bassil Dahiyat directly, you can use the email address **************@xencor.com. Complete contact information is available upon registration with Muraena.
Who is Bassil Dahiyat?
Bassil Dahiyat is an accomplished CEO at Xencor with extensive expertise in the biopharmaceutical and biotechnology sectors. With a PhD in Chemistry from Caltech and a background in Biomedical Engineering from Johns Hopkins University, he has a strong foundation in both scientific research and commercial application. His leadership experience spans over two decades in the industry, where he has contributed to significant advancements in drug development and commercialization. As a board member at Kodiak Sciences, Bassil plays a vital role in guiding innovative research in commercial physical research. His work focuses on critical areas such as cancer, immunology, and infectious diseases, making him a key player in the fight against complex health challenges. Bassil's commitment to technology transfer and R&D reflects his dedication to advancing the life sciences. He is recognized for his strategic vision and ability to drive growth in competitive markets.
Bassil`s contact details
**************@xencor.com
********@kodiak.com
Colleagues
Senior Vice President, Chemical Development & Manufacturing
Executive Director Clinical Sciences
Vice President of Biometrics and Clinical Data Science
Vice President, Biologics Development and Manufacturing
Chief Medical Officer
Executive Vice President, Chief Financial Officer
Chairman and CEO